Crossmark

Effect of sofosbuvir plus daclatasvir on virological response and liver function tests as a line of treatment for HCV related cirrhosis (a prospective cohort study)

Crossref DOI link: https://doi.org/10.1186/s43066-020-00036-w

Published Online: 2020-07-15

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ali, Omaima Mohamed

Hussein, Alaa Aboelela

Kholef, Emad Farah Mohamed

Elsewify, Wael Abd Elgwad
License Information

Text and Data Mining valid from 2020-07-15

Version of Record valid from 2020-07-15
More Information

Article History

Received: 10 February 2020

Accepted: 15 May 2020

First Online: 15 July 2020

Ethics approval and consent to participate

: The study was approved and consent to participate by Local Ethics Committee, Faculty of Medicine, Aswan University; reference number is not available. Informed written consent was obtained from each participant before enrolment in the study.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below